Assessing SGLT-2 Inhibitors in Patients with T2D, Cardiovascular Complications | AHA 2024
November 20th 2024Three research posters presented at the American Heart Association’s 2024 Scientific Sessions looked into the use of SGLT-2 inhibitors in patients with type 2 diabetes and cardiovascular complications.
Exploring Alternative Pain Management Strategies for Headaches and Migraines | AMCP Nexus 2024
October 23rd 2024New research presented at AMCP Nexus 2024 highlighted the effectiveness and cost-effectiveness of various migraine treatments, including onabotulinumtoxinA and fremanezumab, as well as the importance of migraine education programs for improving patient outcomes.